Muscle Growth & Strength Protocol

Protocol Overview

The Muscle Growth & Strength Protocol is designed for intermediate to advanced trainees seeking to maximise muscle hypertrophy and strength gains through enhanced growth hormone signalling and accelerated recovery. This protocol is ideal for bodybuilders, powerlifters, and athletes in strength sports.

Primary Goal: Increase lean muscle mass by 4-6 kg over 12 weeks whilst improving recovery capacity

Target Outcomes:

• Enhanced muscle protein synthesis
• Increased training volume capacity
• Faster recovery between sessions
• Improved sleep quality and body composition
• Reduced injury risk from high-volume training

Peptide Stack

CJC-1295 (No DAC)

Role: Growth hormone secretagogue (long-acting)

• Dose: 100-200 mcg
• Frequency: 2-3x weekly
• Administration: Subcutaneous injection before bed
• Mechanism: Stimulates pulsatile GH release, increases IGF-1 production, enhances protein synthesis

Ipamorelin

Role: Growth hormone secretagogue (short-acting)

• Dose: 200-300 mcg
• Frequency: 2-3x weekly (same days as CJC-1295)
• Administration: Subcutaneous injection before bed (combine with CJC-1295)
• Mechanism: Amplifies GH pulse amplitude, minimal effect on cortisol or prolactin

BPC-157

Role: Recovery and injury prevention

• Dose: 250-500 mcg
• Frequency: Daily
• Administration: Subcutaneous injection post-workout
• Mechanism: Promotes tissue repair, reduces inflammation, supports tendon and ligament health

TB-500

Role: Systemic recovery and tissue regeneration

• Dose: 2-5 mg
• Frequency: Twice weekly
• Administration: Subcutaneous or intramuscular injection
• Mechanism: Promotes cell migration, reduces inflammation, supports muscle recovery

Dosing Schedule

Training Days (4-6x per week)

| Time | Peptide | Dose | |------|---------|------| | Post-Workout | BPC-157 | 250-500 mcg | | Before Bed (Mon/Wed/Fri) | CJC-1295 + Ipamorelin | 100-200 mcg + 200-300 mcg |

Rest Days

| Time | Peptide | Dose | |------|---------|------| | Evening | BPC-157 | 250-500 mcg | | Before Bed (Mon/Wed/Fri) | CJC-1295 + Ipamorelin | 100-200 mcg + 200-300 mcg |

TB-500 Schedule

• Monday: 2-5 mg (any time)
• Thursday: 2-5 mg (any time)

Preparation Instructions

1. Reconstitution: Add 2 ml bacteriostatic water to each peptide vial. For CJC-1295 and Ipamorelin, you can mix both in the same syringe for convenience.
2. Storage: Store all reconstituted peptides at 2-8°C. Use within 2-4 weeks.
3. Supplies: Insulin syringes (0.5-1 ml), alcohol swabs, sharps container
4. Timing: Take CJC-1295 and Ipamorelin on an empty stomach (2-3 hours after last meal) for optimal GH release.

Administration Protocol

Phase 1: Loading (Weeks 1-4)

Goal: Establish elevated GH/IGF-1 levels and assess tolerance

• CJC-1295: 100 mcg, 3x weekly (Mon/Wed/Fri)
• Ipamorelin: 200 mcg, 3x weekly (Mon/Wed/Fri)
• BPC-157: 500 mcg daily
• TB-500: 5 mg twice weekly

Training: Progressive overload, 4-6 sessions weekly, focus on compound movements

Phase 2: Growth (Weeks 5-8)

Goal: Maximise anabolic response and training volume

• CJC-1295: 150-200 mcg, 3x weekly
• Ipamorelin: 250-300 mcg, 3x weekly
• BPC-157: 250-500 mcg daily (adjust based on recovery needs)
• TB-500: 2-5 mg twice weekly

Training: Increase volume by 10-20%, add accessory work, maintain intensity

Phase 3: Consolidation (Weeks 9-12)

Goal: Solidify gains and prepare for post-cycle maintenance

• CJC-1295: 100-150 mcg, 2-3x weekly
• Ipamorelin: 200-250 mcg, 2-3x weekly
• BPC-157: 250 mcg daily
• TB-500: 2 mg twice weekly

Training: Maintain volume, focus on strength progression, deload in week 12

Monitoring & Assessment

Body Composition Tracking (Bi-Weekly)

• Body weight (same time of day, fasted)
• Body fat percentage (callipers, bioimpedance, or DEXA)
• Circumference measurements (chest, arms, thighs, waist)
• Progress photos (front, side, back)

Performance Metrics (Weekly)

• Strength progression on key lifts (1RM or 5RM tests)
• Training volume (sets × reps × weight)
• Recovery quality (1-10 scale)
• Sleep quality (hours and subjective rating)

Blood Work (Recommended)

• Baseline: IGF-1, glucose, HbA1c, liver function, kidney function
• Week 4: IGF-1 (should be 200-400 ng/ml)
• Week 8: IGF-1, glucose, HbA1c
• Week 12: Full panel

Expected Results

• Week 1-2: Improved sleep, faster recovery, slight water retention (+1-2 kg)
• Week 3-4: Increased training capacity, reduced DOMS, strength gains (5-10%)
• Week 5-8: Visible muscle growth (+2-3 kg lean mass), continued strength gains (10-15%)
• Week 9-12: Consolidated gains (+4-6 kg total lean mass), improved body composition

Nutrition Requirements

Protein

• Target: 1.8-2.2 g/kg body weight daily
• Timing: 25-40g per meal, 4-5 meals daily
• Sources: Lean meats, fish, eggs, dairy, whey protein

Calories

• Surplus: +300-500 kcal above maintenance
• Adjust: Based on weekly weight gain (target 0.25-0.5 kg/week)

Carbohydrates

• Target: 4-6 g/kg body weight on training days
• Timing: Pre- and post-workout for optimal performance and recovery

Fats

• Target: 0.8-1.2 g/kg body weight
• Sources: Olive oil, nuts, avocados, fatty fish (omega-3s)

Hydration

• Target: 3-4 litres daily, more on training days

Training Recommendations

Frequency

4-6 sessions per week, split by muscle groups or movement patterns

Volume

• Weeks 1-4: 12-16 sets per muscle group per week
• Weeks 5-8: 16-20 sets per muscle group per week
• Weeks 9-12: 14-18 sets per muscle group per week (deload week 12)

Intensity

• Primary lifts: 70-85% 1RM, 3-6 reps
• Accessory work: 65-75% 1RM, 8-12 reps
• Isolation: 60-70% 1RM, 12-15 reps

Rest Periods

• Compound lifts: 2-3 minutes
• Accessory work: 60-90 seconds
• Isolation: 45-60 seconds

Research Evidence

CJC-1295 & Ipamorelin

• Increases IGF-1 levels by 20-50% in clinical studies
• Improves lean body mass by 10-30% over 12 weeks
• Enhances sleep quality and recovery markers
• Minimal side effects compared to exogenous GH

BPC-157

• Accelerates muscle repair and reduces inflammation
• Protects tendons and ligaments during high-volume training
• Over 100 animal studies supporting tissue healing properties

TB-500

• Phase 2 clinical trials for tissue repair and wound healing
• Promotes muscle regeneration and reduces fibrosis
• Supports cardiovascular health and endurance

UK-Specific Guidance

Lab Testing

• Medichecks: Sports Hormone Check (£149) - includes IGF-1, testosterone, cortisol
• Thriva: Advanced Fitness Panel (£199) - comprehensive metabolic and hormone markers
• Recommended frequency: Baseline, week 4, week 8, week 12

Sourcing

Research-grade peptides available from UK suppliers. Verify third-party testing (HPLC, mass spectrometry). Expect to pay £200-£400 for a 12-week supply.

Legal Status

The MHRA classifies these peptides as research compounds. Legal to purchase for research purposes but not approved for human therapeutic use. This protocol is for educational purposes only.

NHS Considerations

If you're receiving NHS treatment or have pre-existing conditions, inform your GP about any research compounds you're using. Regular blood work is essential for monitoring safety.

Safety Considerations

Contraindications

• Active cancer or history of cancer
• Diabetes (monitor blood glucose closely)
• Pregnancy or breastfeeding
• Age under 25 (natural GH levels are optimal)

Side Effects

Common (usually mild and temporary):

• Water retention (1-2 kg)
• Joint discomfort or stiffness
• Numbness or tingling in extremities
• Increased hunger
• Temporary fatigue

Rare:

• Elevated blood glucose
• Headaches
• Injection site reactions

Risk Mitigation

• Start with lower doses and assess tolerance
• Monitor blood glucose if diabetic or pre-diabetic
• Stay hydrated to reduce water retention
• Rotate injection sites
• Take breaks between cycles (4-8 weeks off after 12 weeks on)

Cost Estimate (UK)

| Item | Cost (12 weeks) | |------|-----------------| | CJC-1295 No DAC (2mg x 6 vials) | £120-£180 | | Ipamorelin (5mg x 6 vials) | £150-£220 | | BPC-157 (5mg x 8 vials) | £160-£240 | | TB-500 (5mg x 8 vials) | £240-£360 | | Bacteriostatic water | £20-£30 | | Insulin syringes (100 pack) | £10-£15 | | Blood work (3 tests) | £300-£450 | | Total | £1,000-£1,495 |

Post-Cycle Maintenance

After completing the 12-week protocol:

1. Taper: Reduce doses by 50% in final week
2. Break: Take 4-8 weeks off all peptides
3. Maintain: Continue training and nutrition to preserve gains
4. Assess: Evaluate results and decide if another cycle is warranted

Most users retain 70-80% of muscle gains post-cycle with proper training and nutrition.

Frequently Asked Questions

Can I use this protocol while cutting?

Yes, but adjust to a moderate calorie deficit (-300 to -500 kcal). GH secretagogues help preserve muscle mass during fat loss. Expect slower muscle gains but improved body composition.

Do I need to cycle off?

Yes, 4-8 weeks off after 12 weeks on is recommended to maintain natural GH sensitivity and prevent desensitisation.

Can I add other peptides?

Advanced users may add Hexarelin or GHRP-6 for additional GH stimulation, but this increases side effect risk. Not recommended for first cycle.

Will I lose my gains after stopping?

You'll retain most muscle gains (70-80%) with proper training and nutrition. Some water weight will be lost immediately.

Is this better than exogenous growth hormone?

Peptides stimulate natural GH production, which is safer and more physiological. Exogenous GH suppresses natural production and carries higher risks.

References

1. Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805.
2. Gobburu JV, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin. J Clin Pharmacol. 2001;41(9):1032-41.
3. Seiwerth S, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-5.
4. Goldstein AL, et al. Thymosin beta4: a multi-functional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51.

---

Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use. Peptide use in competitive sports may violate anti-doping regulations.